홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /화합물

Medazepam

HCID 4041
새 반응
인쇄
기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
2898-12-6
표준 SMILES
CN1CCN=C(c2ccccc2)c2cc(Cl)ccc21
InChIKey
YLCXGBZIZBEVPZ-UHFFFAOYSA-N
분자식
C16H15ClN2
평균 분자량
270.75 g/mol
단동위원소 질량
270.0923762

개요

Medazepam is an organic molecular entity.

이름 및 식별자

우선 이름
Medazepam
IUPAC
7-chloro-1-methyl-5-phenyl-2,3-dihydro-1,4-benzodiazepine
영어명
MEDAZEPAM
분자식
C16H15ClN2
분자량
270.76

이름 및 동의어

medazepamPamnace2898-12-6MedazepamumDTXSID1048708P0J3387W3SDTXCID80286347-Chloro-1-methyl-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepineRefChem:810832N05BA03Ro 54556Ro 5 4556
이름 더 보기
SimanDiepinElbrusEsmailAnsilanmezapamMezepan
220-783-4ResmitNobriumRudotelEnobrinNiveltonNarsis7-Chloro-2,3-dihydro-1-methyl-5-phenyl-1H-1,4-benzodiazepine

데이터베이스 식별자

CAS
2898-12-6
PubChem CID
4041
DTXSID
DTXSID1048708
ChEMBL
CHEMBL28333
ChEBI
CHEBI:31807
UNII
P0J3387W3S
EC Number
220-783-4
Nikkaji
J2.167I

물성

구조 계산 물성

XLogP
4.4
극성 표면적
15.6 Ų
수소 결합 공여자 수
0
수소 결합 수용자 수
2
회전 가능 결합 수
1
무거운 원자 수
19
형식 전하
0
복잡도
336

실험 및 물리화학적 성질

Drugs · 5건

DEA NFLIS-Drug Category -> Benzodiazepines

DEA Schedule IV Controlled Substance -> Depressants

Pharmaceuticals -> Benzodiazepines

Pharmaceuticals -> Synthetic Cannabinoids or Psychoactive Compounds

Pharmaceuticals

SpringerMaterials PropertiesFusion temperature
LogP3.3
Human DrugsPharmaceuticals
Collision Cross Section160.8 Ų [M+H]+ [CCS Type: TW; Method: Major Mix IMS/Tof Calibration Kit (Waters)]

물리화학적 성질

녹는점
95 · 95-97°
끓는 점
420.36 °C · 420.36°C (rough estimate)
밀도
1.1336 · 1.1336 (rough estimate)
굴절률
1.5749 · 1.5749 (estimate)
저장 조건
-20 °C · -20°C
용해도
메탄올(약간 용해됨), 물(약간 용해됨)
물리적 상태
고체
산도 계수 (pKa)
6.2 · pKa 6.2(H2O) (Uncertain)
색상
노란색에서 주황색으로
수용성
10.83 mg/L · 10.83mg/L(37℃)
주요 응용
임상 시험
InChI
1S/C16H15ClN2.ClH/c1-19-10-9-18-16(12-5-3-2-4-6-12)14-11-13(17)7-8-15(14)19;/h2-8,11H,9-10H2,1H3;1H
InChIKey
XBWAZCLHZCFCGK-UHFFFAOYSA-N
SMILES
Clc1cc2c(cc1)N(CCN=C2c3ccccc3)C.Cl

안전 및 규제

안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.

GHS 분류

GHS Classification · 4건

Warning

H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]

P203, P260, P261, P263, P264, P270, P271, P280, P301+P317, P304+P340, P318, P319, P330, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 31 reports by companies from 3 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

유해성 정보

Regulatory InformationDEA schedule IV controlled substance
Other Safety InformationIMAP assessments - 1H-1,4-Benzodiazepine, 7-chloro-2,3-dihydro-1-methyl-5-phenyl-: Environment tier I assessment
Hazard Classes and CategoriesAcute Tox. 4 (100%)

독성 정보

Treatment · 1건

General supportive measures should be employed, along with intravenous fluids, and an adequate airway maintained. Hypotension may be combated by the use of norepinephrine or metaraminol. Dialysis is of limited value. Flumazenil (Anexate) is a competitive benzodiazepine receptor antagonist that can be used as an antidote for benzodiazepine overdose. In particular, flumazenil is very effective at reversing the CNS depression associated with benzodiazepines but is less effective at reversing respiratory depression. Its use, however, is controversial as it has numerous contraindications. It is contraindicated in patients who are on long-term benzodiazepines, those who have ingested a substance that lowers the seizure threshold, or in patients who have tachycardia or a history of seizures. As a general rule, medical observation and supportive care are the mainstay of treatment of benzodiazepine overdose. Although benzodiazepines are absorbed by activated charcoal, gastric decontamination with activated charcoal is not beneficial in pure benzodiazepine overdose as the risk of adverse effects often outweigh any potential benefit from the procedure. It is recommended only if benzodiazepines have been taken in combination with other drugs that may benefit from decontamination. Gastric lavage (stomach pumping) or whole bowel irrigation are also not recommended.

Toxicity Summary · 1건

Benzodiazepines bind nonspecifically to benzodiazepine receptors BNZ1, which mediates sleep, and BNZ2, which affects affects muscle relaxation, anticonvulsant activity, motor coordination, and memory. As benzodiazepine receptors are thought to be coupled to gamma-aminobutyric acid-A (GABAA) receptors, this enhances the effects of GABA by increasing GABA affinity for the GABA receptor. Binding of the inhibitory neurotransmitter GABA to the site opens the chloride channel, resulting in a hyperpolarized cell membrane that prevents further excitation of the cell.

Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).

안전 데이터

wgk
WGK 2
ridadr
3249
독성
LD50 in mice (mg/kg): 360 i.p., 1070 orally (Randall)
risk_code
22
hazard_code
Xn
포장분류
III
위험 등급
6.1(b)
Hazard Classifications
Acute Tox. 3 DermalAcute Tox. 3 InhalationAcute Tox. 3 OralFlam. Liq. 2STOT SE 1
스토리지 클래스
3 - Flammable liquids
DEA Controlled Substances
CSCN: 2836CSA SCH: Schedule IVNARC: No

화학 및 산업

약리 정보

ATC Code · 2건

N - Nervous system

QN - Nervous system

MeSH Pharmacological Classification · 5건

Drugs used to prevent SEIZURES or reduce their severity.

Drugs used to induce drowsiness or sleep or to reduce psychological excitement or anxiety.

A heterogeneous group of drugs used to produce muscle relaxation, excepting the neuromuscular blocking agents. They have their primary clinical and therapeutic uses in the treatment of muscle spasm and immobility associated with strains, sprains, and injuries of the back and, to a lesser degree, injuries to the neck. They have been used also for the treatment of a variety of clinical conditions that have in common only the presence of skeletal muscle hyperactivity, for example, the muscle spasms that can occur in MULTIPLE SCLEROSIS. (From Smith and Reynard, Textbook of Pharmacology, 1991, p358)

Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here.

Substances that do not act as agonists or antagonists but do affect the GAMMA-AMINOBUTYRIC ACID receptor-ionophore complex. GABA-A receptors (RECEPTORS, GABA-A) appear to have at least three allosteric sites at which modulators act: a site at which BENZODIAZEPINES act by increasing the opening frequency of GAMMA-AMINOBUTYRIC ACID-activated chloride channels; a site at which BARBITURATES act to prolong the duration of channel opening; and a site at which some steroids may act. GENERAL ANESTHETICS probably act at least partly by potentiating GABAergic responses, but they are not included here.

용도 및 제조

Use ClassificationPharmaceuticals

응용 분야

용도Tranquilizer (minor).

상·하류 제품 정보

상류 원료

수산화나트륨2-브로모에틸아민 브롬화수소산염Phosphorus oxychloride무수초산탄산칼슘옥살산

관련 반응

6건
반응 기록 만들기
HRID 168647 반응식
HRID 168647생성물로
HRID 262945 반응식
HRID 262945생성물로
HRID 441939 반응식
HRID 441939생성물로
HRID 441940 반응식
HRID 441940생성물로
HRID 1113120 반응식
HRID 1113120생성물로
HRID 1212979 반응식
HRID 1212979생성물로

화합물 노트

이 페이지에서기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트